Keywords
Hypothyroidism
Ultrasonography
Histopathology
How to Cite
Abstract
Hypothyroidism is a widespread condition affecting people of different socio-economic background and geographical location. A lot of studies highlight the effect of hypothyroidism on the metabolic processes in various organs, including the liver. On the other hand, liver damage often results in the development of non-alcoholic fatty liver disease; however, the data on the impact of hypothyroidism on liver morphology, which can serve as a direct indicator and marker of liver condition and function, are limited and controversial. In this report, we reviewed the relationship between non-alcoholic fatty liver disease and hypothyroidism with an accent on morphological alteration of the liver discovered in clinical and experimental studies.
References
Toloza FJK, Mao Y, Menon L, George G, Borikar M, Thumma S, et al. Association of thyroid function with suicidal behavior: a systematic review and meta-analysis. Medicina. 2021;57(7):714. Available from: https://doi.org/10.3390/medicina57070714
Taylor PN, Albrecht D, Scholz A, Gutierrez-Buey G, Lazarus JH, Dayan CM, et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nature Reviews Endocrinology. 2018;14(5):301–316. Available from: https://doi.org/10.1038/nrendo.2018.18
Chiovato L, Magri F, Carlé A. Hypothyroidism in context: where we’ve been and where we’re going. Advances in Therapy. 2019;36(S2):47–58. Available from: https://doi.org/10.1007/s12325-019-01080-8
Wiersinga WM. Guidance in subclinical hyperthyroidism and subclinical hypothyroidism: are we making progress? European Thyroid Journal. 2015;4(3):143–148. Available from: https://doi.org/10.1159/000438909
Biondi B, Cappola AR, Cooper DS. Subclinical hypothyroidism. JAMA. 2019;322(2):153. Available from: https://doi.org/10.1001/jama.2019.9052
D’Ambrosio R, Campi I, Maggioni M, Perbellini R, Giammona E, Stucchi R, et al. The relationship between liver histology and thyroid function tests in patients with non-alcoholic fatty liver disease (NAFLD). PLOS ONE. 2021;16(4):e0249614. Available from: https://doi.org/10.1371/journal.pone.0249614
Notariza KR, Wisnu W. The risk of developing non-alcoholic fatty liver disease in adult patients with subclinical hypothyroidism compared to euthyroid: an evidence-based case report. Acta Med Indones. 2019;51(2):179-188. Available from: http://www.actamedindones.org/index.php/ijim/article/view/907/pdf
Kizivat T, Maric I, Mudri D, Curcic IB, Primorac D, Smolic M. Hypothyroidism and nonalcoholic fatty liver disease: pathophysiological associations and therapeutic implications. Journal of Clinical and Translational Hepatology. 2020;8(3):1–7. Available from: https://doi.org/10.14218/JCTH.2020.00027
Tanase DM, Gosav EM, Neculae E, Costea CF, Ciocoiu M, Hurjui LL, et al. Hypothyroidism-induced nonalcoholic fatty liver disease (HIN): mechanisms and emerging therapeutic options. International Journal of Molecular Sciences. 2020;21(16):5927. Available from: https://doi.org/10.3390/ijms21165927
Lonardo A, Mantovani A, Lugari S, Targher G. NAFLD in some common endocrine diseases: prevalence, pathophysiology, and principles of diagnosis and management. International Journal of Molecular Sciences. 2019;20(11):2841. Available from: https://doi.org/10.3390/ijms20112841
Mansour-Ghanaei F, Joukar F, Mobaraki SN, Mavaddati S, Hassanipour S, Sepehrimanesh M. Prevalence of non-alcoholic fatty liver disease in patients with diabetes mellitus, hyperlipidemia, obesity and polycystic ovary syndrome: a cross-sectional study in north of Iran. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019;13(2):1591–1596. Available from: https://doi.org/10.1016/j.dsx.2019.03.009
Manka P, Bechmann L, Best J, Sydor S, Claridge LC, Coombes JD, et al. Low free triiodothyronine is associated with advanced fibrosis in patients at high risk for nonalcoholic steatohepatitis. Digestive Diseases and Sciences. 2019;64(8):2351–2358. Available from: https://doi.org/10.1007/s10620-019-05687-3
Chang T-Y, Chang S-H, Lin Y-H, Ho W-C, Wang C-Y, Jeng W-J, et al. Utility of quantitative ultrasound in community screening for hepatic steatosis. Ultrasonics. 2021;111:106329. Available from: https://doi.org/10.1016/j.ultras.2020.106329
Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. BMJ. 1986;292(6512):13–15. Available from: https://doi.org/10.1136/bmj.292.6512.13
Kondo R, Kusano H, Mihara Y, Kage M, Akiba J, Yano H. Pathological findings of liver steatosis that is difficult to evaluate with ultrasound. Journal of Medical Ultrasonics. 2021;48:515-522. Available from: https://doi.org/10.1007/s10396-021-01126-x
Petzold G, Lasser J, Rühl J, Bremer SCB, Knoop RF, Ellenrieder V, et al. Diagnostic accuracy of B-Mode ultrasound and Hepatorenal Index for graduation of hepatic steatosis in patients with chronic liver disease. PLOS ONE. 2020;15(5):e0231044. Available from: https://doi.org/10.1371/journal.pone.0231044
Shetty D, Amarapurkar A, Shukla A. Primary versus secondary NAFLD: perspective on advanced fibrosis. Journal of Clinical and Experimental Hepatology. 2021;11(5):557–564. Available from: https://doi.org/10.1016/j.jceh.2020.12.009
Sharpton SR, Tamaki N, Bettencourt R, Madamba E, Jung J, Liu A, et al. Diagnostic accuracy of two-dimensional shear wave elastography and transient elastography in nonalcoholic fatty liver disease. Therapeutic Advances in Gastroenterology. 2021;14:175628482110504. Available from: https://doi.org/10.1177/17562848211050436
Taibbi A, Petta S, Matranga D, Caruana G, Cannella R, Busè G, et al. Liver stiffness quantification in biopsy-proven nonalcoholic fatty liver disease patients using shear wave elastography in comparison with transient elastography. Ultrasonography. 2021;40(3):407–416. Available from: https://doi.org/10.14366/usg.20147
Choi SY, Yi DY, Kim SC, Kang B, Choe B-H, Lee Y, et al. Severe phenotype of non-alcoholic fatty liver disease in pediatric patients with subclinical hypothyroidism: a retrospective multicenter study from Korea. Journal of Korean Medical Science. 2021;36(20). Available from: https://doi.org/10.3346/jkms.2021.36.e137
Grewal H, Joshi S, Sharma R, Mittal P, Goel A. Non-alcoholic fatty liver disease in patients with hypothyroidism presenting at a rural tertiary care centre in north India. Tropical Doctor. 2020;51(2):181-184. Available from: https://doi.org/10.1177/0049475520945058
Tahara K, Akahane T, Namisaki T, Moriya K, Kawaratani H, Kaji K, et al. Thyroid‐stimulating hormone is an independent risk factor of non‐alcoholic fatty liver disease. JGH Open. 2019;4(3):400–404. Available from: https://doi.org/10.1002/jgh3.12264
Kim D, Kim W, Joo SK, Bae JM, Kim JH, Ahmed A. Subclinical hypothyroidism and low-normal thyroid function are associated with nonalcoholic steatohepatitis and fibrosis. Clinical Gastroenterology and Hepatology. 2018;16(1):123–131.e1. Available from: https://doi.org/10.1016/j.cgh.2017.08.014
Bano A, Chaker L, Plompen EPC, Hofman A, Dehghan A, Franco OH, et al. Thyroid function and the risk of nonalcoholic fatty liver disease: the Rotterdam study. The Journal of Clinical Endocrinology & Metabolism. 2016;101(8):3204–3211. Available from: https://doi.org/10.1210/jc.2016-1300
Kim HJ. Importance of thyroid-stimulating hormone levels in liver disease. Journal of Pediatric Endocrinology and Metabolism. 2020;33(9):1133–1137. Available from: https://doi.org/10.1515/jpem-2020-0031
Gökmen F, Ahbab S, Ataoğlu H, Türker B, Çetin F, Türker F, et al. FT3/FT4 ratio predicts non-alcoholic fatty liver disease independent of metabolic parameters in patients with euthyroidism and hypothyroidism. Clinics. 2016;71(4):221–225. Available from: https://doi.org/10.6061/clinics/2016(04)08
Kotyk T, Tokaruk N, Bedej V, Hryshchuk M, Popadynets O, Kolinko Y, et al. Multi-step clustering approach of myelinated nerve fibers in experimental neuromorphology. International Journal of Ambient Computing and Intelligence. 2021;12(2):73–91. Available from: https://doi.org/10.4018/IJACI.2021040105
Chalouati H, Gamet-Payrastre L, Saad MB. Irreversible thyroid disruption induced after subchronic exposure to hexachlorobenzene in male rats. Toxicology and Industrial Health. 2013;32(5):822–831. Available from: https://doi.org/10.1177/0748233713511511
Jiang L-Q, Chen S-J, Xu J-J, Ran Z, Ying W, Zhao S-G. Dronedarone and amiodarone induce dyslipidemia and thyroid dysfunction in rats. Cellular Physiology and Biochemistry. 2016;38(6):2311–2322. Available from: https://doi.org/10.1159/000445585
Sarkar D, Chakraborty A, Saha A, Chandra AK. Iodine in excess in the alterations of carbohydrate and lipid metabolic pattern as well as histomorphometric changes in associated organs. Journal of Basic and Clinical Physiology and Pharmacology. 2018;29(6):631–643. Available from: https://doi.org/10.1515/jbcpp-2017-0204
Duan J, Kang J, Deng T, Yang X, Chen M. Exposure to DBP and high iodine aggravates autoimmune thyroid disease through increasing the levels of IL-17 and thyroid-binding globulin in Wistar rats. Toxicological Sciences. 2018;163(1):196–205. Available from: https://doi.org/10.1093/toxsci/kfy019
Mohibbullah M, Bashir KMI, Kim S, Hong Y, Kim A, Ku S, et al. Protective effects of a mixed plant extracts derived from Astragalus membranaceus and Laminaria japonica on PTU‐induced hypothyroidism and liver damages. Journal of Food Biochemistry. 2019;43(7). Available from: https://doi.org/10.1111/jfbc.12853
Lee W-Y, Yi S-J, Yun S, Oh T-H, Kim H-T, Lim M-K, et al. Hepatoprotective effect of blue honeysuckle on rat hypothyroidism. Journal of Veterinary Clinics. 2017;34(6):404–409. Available from: https://doi.org/10.17555/jvc.2017.12.34.6.404
Tasci HI, Erikoglu M, Toy H, Karaibrahimoglu A. Course of sepsis in rats with thyroid dysfunction. Turkish Journal of Surgery. 2017;33(3):175–179. Available from: https://doi.org/10.5152/turkjsurg.2017.3621
Panda S, Kar A, Singh M, Singh RK, Ganeshpurkar A. Syringic acid, a novel thyroid hormone receptor‐β agonist, ameliorates propylthiouracil‐induced thyroid toxicity in rats. Journal of Biochemical and Molecular Toxicology. 2021;35(8). Available from: https://doi.org/10.1002/jbt.22814
Bunker SK, Dutta A, Pradhan J, Dandapat J, Chainy GBN. Curcumin restores hepatic epigenetic changes in propylthiouracil(PTU) Induced hypothyroid male rats: A study on DNMTs, MBDs, GADD45a, C/EBP-β and PCNA. Food and Chemical Toxicology. 2019;123:169–180. Available from: https://doi.org/10.1016/j.fct.2018.10.050
Baki AM, Aydın AF, Vural P, et al. α-lipoic acid ameliorates the changes in prooxidant-antioxidant balance in liver and brain tissues of propylthiouracil-induced hypothyroid rats. Cell Journal. 2020;22:117–124. Available from: https://doi.org/10.22074/cellj.2020.7049
Ustun YB, Kaya C, Koksal E, Atalay Y, Yilmaz Z, Torun AC, et al. Effects of the administration of thyroid hormones in cases of hepatic ischemia and reperfusion injury. International Surgery. 2018;103(5-6):260–269. Available from: https://doi.org/10.9738/INTSURG-D-17-00108.1
Ayuob NN, Abdel-Hamid AAHM, Helal GMM, Mubarak WA. Thymoquinone reverses nonalcoholic fatty liver disease (NAFLD) associated with experimental hypothyroidism. Romanian journal of morphology and embryology. 2019;60:479-486.
Demir Ş, Ünübol M, Aypak SÜ, İpek E, Aktaş S, Ekren GS, et al. Histopathologic evaluation of nonalcoholic fatty liver disease in hypothyroidism-induced rats. International Journal of Endocrinology. 2016;2016:1–7. Available from: https://doi.org/10.1155/2016/5083746
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.